Vulvar Cancer Stage Ib
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Vulvar Cancer Stage Ib trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Vulvar Cancer Stage Ib trials you may qualify forIndependently developed by Sichuan Yingrui Pharmaceutical Technology Co., Ltd., CNSI-Fe is an innovative anti-cancer drug with Fe2+ as the active ingredient, wh…
This study is an open label, prospective, experimental, randomised clinical trial. The primary aim of this study is to determine whether it is feasible to rando…
The study will consist of two parts : In the phase Ib: safety will be assessed in consecutive cohorts of 3 to 6 participants at increasing doses of TG4001 in c…
This trial studies the prevalence of anal dysplasia and anal cancer in patients with cervical, vaginal, and vulvar dysplasia and cancer. Studying samples collec…